Pepper GS, Lee RW (1999) Sympathetic activation in heart failure and its treatment with β-blockade. Archives Internal Med 159(3):225–234
Article
CAS
Google Scholar
Morris MJ, Cox HS, Lambert GW, Kaye DM, Jennings GL, Meredith IT, Esler MD (1997) Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans. Hypertension 29(1):137–143
Article
CAS
PubMed
Google Scholar
Regitz V, Leuchs B, Bossaller C, Sehested J, Rappolder M, Fleck E (1991) Myocardial catecholamine concentrations in dilated cardiomyopathy and heart failure of different origins. Eur Heart J 12(suppl_D):171–174
Article
PubMed
Google Scholar
Tomiyama H, Kushiro T, Abeta H, Ishii T, Takahashi A, Furukawa L, Otsuka Y (1994) Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor. Hypertension 23(4):450–455
Article
CAS
PubMed
Google Scholar
Dzau VJ, Colucci WS, Hollenberg NK, Williams GH (1981) Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 63(3):645–651
Article
CAS
PubMed
Google Scholar
Scherrer U, Sartori C (1997) Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 96(11):4104–4113
Article
CAS
PubMed
Google Scholar
Marangou AG, Alford FP, Ward G, Liskaser F et al (1988) Hormonal effects of norepinephrine on acute glucose disposal in humans: a minimal model analysis. Metabolism 37(9):885–891
Article
CAS
PubMed
Google Scholar
Sacca L, Morrone G, Cicala M, Corso G, Ungaro B (1980) Influence of epinephrine, norepinephrine, and isoproterenol on glucose homeostasis in normal man. J Clin Endocrinol Metabolism 50(4):680–684
Article
CAS
Google Scholar
Lembo, G., Napoli, R., Capaldo, B., Rendina, V., Iaccarino, G., Volpe, M., ...& Saccà, L. Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J Clin Investigation 1992; 90(1), 24-29.
O’Hare JA, Minaker KL, Meneilly GS, Rowe JW, Pallotta JA, Young JB (1989) Effect of insulin on plasma norepinephrine and 3, 4-dihydroxyphenylalanine in obese men. Metabolism 38(4):322–329
Article
PubMed
Google Scholar
Grassi, G., Seravalle, G., Cattaneo, B. M., Bolla, G. B., Lanfranchi, A., Colombo, M., ...& Mancia, G. Sympathetic activation in obese normotensive subjects. Hypertension 1995; 25(4), 560-563.
Swan JW, Anker SD, Walton C, Godsland IF, Clark AL, Leyva F, Coats AJ (1997) Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am College Cardiol 30(2):527–532
Article
CAS
Google Scholar
Jacob S, Rett K, Wicklmayr M, Agrawal B, Augustin HJ, Dietze GJ (1996) Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study. J Hypertension 14(4):489–494
Article
CAS
Google Scholar
Pollare T, Lithell H, Selinus I, Berne C (1989) Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. Brit Med J 298(6681):1152–1157
Article
CAS
PubMed
PubMed Central
Google Scholar
Enright PL, McBurnie MA, Bittner V, Tracy RP, McNamara R, Arnold A, Newman AB (2003) The 6-min walk test: a quick measure of functional status in elderly adults. Chest 123(2):387–398
Article
PubMed
Google Scholar
Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ (1998) Nitric oxide availability in diabetes mellitus. Diabetes/Metabolism Review 14(3):241–249
Article
CAS
Google Scholar
Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27(6):1487–1495
Article
PubMed
Google Scholar
Balkau, B., , Charles, M.A. Comment on the provisional report from the WHO consultation European group for the study of insulin resistance (EGIR). Diabet Med 1999; 16: 442-443.
Article
CAS
PubMed
Google Scholar
Eriksson BM, Persson BA (1982) Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection. J Chromaogr 228:143–154
Article
CAS
Google Scholar
Ponikowski P, Voors AA, Anker SD et al (2016) 2006 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200
Article
PubMed
Google Scholar
Manrique C, Lastra G, Habibi J, Pulakat L, Schneider R, Durante W, Whaley-Connell A (2011) Nebivolol improves insulin sensitivity in the TGR (Ren2) 27 rat. Metabolism 60(12):1757–1766
Article
CAS
PubMed
PubMed Central
Google Scholar
Hitomi, H., Kiyomoto, H., Nishiyama, A., Hara, T., Moriwaki, K., Kaifu, K., ...& Kohno, M. Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells. Hypertension 2007 50(4), 750-755.
Refsgaard J, Thomsen C, Andreasen F, Gøtzsche O (2002) Carvedilol does not alter the insulin sensitivity in patients with congestive heart failure. Eur J Heart Failure 4:445–453
Article
CAS
Google Scholar
Ferrua, S., Bobbio, M., Catalano, E., Grassi, G., Massobrio, N., Pinach, S., ... & Trevi, G. P. . Does carvedilol impair insulin sensitivity in heart failure patients without diabetes?. J Cardiac Failure 2005; 11(8), 590-594.
Lechat, P. H., Boutelant, S., Komajda, M., Gagey, et al. Pilot study of cardiovascular effects of nebivolol in congestive heart failure. Drug Investigation 1991; 3(1), 69-81.
Ayers K, Byrne LM, DeMatteo A, Brown NJ (2012) Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome. Hypertension 59(4):893–898
Article
CAS
PubMed
Google Scholar
De Groote, P., Delour, P., Lamblin, N., et al .Effects of bisoprolol in patients with stable congestive heart failure. In Annales de Cardiologie et d'Angeiologie 2004 (Vol. 53, No. 4, pp. 167-170).
Azevedo, E. R., Kubo, T., Mak, S., Al-Hesayen, A., Schofield, A., Allan, R., ... & Parker, J. D. . Nonselective versus selective β-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity. Circulation 2001 104(18), 2194-2199.
Grundemar L, Håkanson R (1993) Multiple neuropeptide Y receptors are involved in cardiovascular regulation. Peripheral and central mechanisms. General Pharmacology: The Vascular System 24(4):785–796
Article
CAS
PubMed
Google Scholar
Ogino K, Kinugasa Y, Kato M, Yamamoto K, Hisatome I, Anker SD, Doehner W (2014) Spironolactone, not furosemide, improved insulin resistance in patients with chronic heart failure. Int J Cardiol 171(3):398–403
Article
PubMed
Google Scholar
Kodaman N, Aldrich MC, Sobota R et al (2016) Plasminogen activator inhibitor-1 and diagnosis of the metabolic syndrome in a West African population. J Am Heart Assoc 5(10):e003867
Article
PubMed
PubMed Central
Google Scholar